FindTrial
Sign In

Therapeutic effect of inhaled budesonide (Pulmicort Turbuhaler) on lung inflammatory response to the one lung ventilation

Therapeutic effect of inhaled budesonide (Pulmicort Turbuhaler) on lung inflammatory response to the one lung ventilation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002459
Enrollment
Unknown
Registered
2012-08-22
Start date
2012-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

group C:nebulized saline
group T:nebulized budesonide

Sponsors

Department of ICU, The Affiliated Tumor Hospital, Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 60 patients aged 20 to 60, ASA I-II which undergoing the lobectomy for lung cancer.

Exclusion criteria

Exclusion criteria: Non lung cancer patients, patients with immune dysfunction, radiotherapy and chemotherapy, pleural effusion, lung infection, hypoproteinemia, COPD and asthma will be excluded.

Design outcomes

Primary

MeasureTime frame
arterial blood analysis;Peak, Plate;lung compliance;IL-1;IL-6;IL-8;TNF-alpha;—

Countries

China

Contacts

Public ContactJU Ying-nan
juyingnan1981@sina.com+86 13804560454

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026